Search
Longeveron Inc
LGVNAdd to Watchlist
2.810USD
-0.100-3.44%
Market hours 09/25, 10:04（ET）
88.80MMarket Cap
LossP/E TTM
Longeveron Inc (LGVN) Revenue Performance
Updated: Jun 30, 2026By Business
Revenue
Proportion
Annual
Annual
Quarterly
Clinical trial revenue
Contract manufacturing
Contract manufacturing lease revenue
National Institutes of Health – Grant
Maryland – TEDCO – Grant
Alzheimer’s Association – Grant
FY2025
FY2024
FY2023
FY2022
FY2021
Clinical trial revenue
954.00K(79.57%)
1.40M(58.61%)
668.00K(94.22%)
940.00K(76.92%)
708.00K(54.21%)
Contract manufacturing
222.00K(18.52%)
487.00K(20.36%)
--(--)
--(--)
--(--)
Contract manufacturing lease revenue
23.00K(1.92%)
503.00K(21.03%)
--(--)
--(--)
--(--)
National Institutes of Health – Grant
--(--)
--(--)
41.00K(5.78%)
164.00K(13.42%)
212.00K(16.23%)
Maryland – TEDCO – Grant
--(--)
--(--)
--(--)
118.00K(9.66%)
126.00K(9.65%)
Alzheimer’s Association – Grant
--(--)
--(--)
--(--)
--(--)
260.00K(19.91%)